Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
424.00    -15.00 (-3.42%)
Bid:
426.00
Ask:
430.00
Spread: 4.00 (0.939%)
Market Cap: £208.53m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Coveris using MuCell® technology

9 Mar 2017 07:00

RNS Number : 9276Y
Zotefoams PLC
09 March 2017
 

RNS Reach announcement

 

 

 

Zotefoams plc

("Zotefoams" or "the Company")

 

Coveris using MuCell® technology to produce polystyrene-free packaging

 

Next generation in lightweight technology provides a cost-effective, ecological and resource-saving packaging solution

 

 

9 March 2017 - Zotefoams plc, a world leader in cellular materials technology, announces that Coveris Holdings S.A. (Coveris), a leading international manufacturing company, is now using MuCell® technology to produce a polystyrene-free packaging solution, known as NEOCELL® PP+, on a commercial basis.

 

NEOCELL® PP+ is the first thermoformed polypropylene (PP) sheet in the form-fill-seal (FFS) industry which is dominated by polystyrene (PS) packaging. The PP material guarantees the same output and efficiency as PS with the addition of improved price stability, excellent thermoforming capabilities and a significant carbon footprint reduction.

 

The development of NEOCELL® PP+ was driven by the need to provide an ecological and resource-saving packaging solution, while enhancing overall cost-effectiveness. NEOCELL® PP+ eliminates the need for chemical foaming agents using MuCell technology for injection of inert gas, resulting in a 26% reduction in product weight compared to PS. In addition, variable density regulation by injecting the optimal amount of gas generates material savings. Under the terms of the agreement, MuCell Extrusion LLC, a wholly owned subsidiary of Zotefoams plc, has licensed its technology to Coveris with a fee payable as a percentage of cost savings.

 

David Stirling, Group CEO of Zotefoams plc, said:

"We are very pleased to be working with Coveris to produce the innovative NEOCELL® PP+ polystyrene-free packaging solution. This partnership further exemplifies the financial and environmental benefits that MuCell™ Extrusion technology can deliver."

 

Coveris is dedicated to providing solutions that enhance the safety, quality and convenience of every day products. Coveris' NEOCELL® PP+ has opened a new chapter with its ground-breaking and innovative PS-free packaging solution for all kinds of FFS applications, for use in sectors such as the dairy industry. For example, NEOCELL® PP+ has been developed as a breakable PP FFS sheet, making it ideal for use in yoghurt pots so they can be easily detached from each other when in packs.

 

- Ends -

 

 

Enquiries:

 

Zotefoams plc

+44 (0)208 664 1600

David Stirling, Group CEO

Gary McGrath, Finance Director

FTI Consulting

+44 (0)203 727 1000

Victoria Foster Mitchell / Simon Conway

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT® insulation products).

 

www.zotefoams.com 

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

 

About Coveris Holdings S.A.

As a leading international manufacturing company, Coveris is dedicated to providing solutions that enhance the safety, quality and convenience of products we use every day. In partnership with the most respected brands in the world, Coveris develops vital products that protect everything from the food we eat, to medical supplies, to the touch screen device in our pockets, contributing to the lives of millions every day. Coveris is an affiliated portfolio company of Sun Capital Partners, Inc.

 

www.coveris.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAKVLFBDXFBBBE
Date   Source Headline
27th May 20264:06 pmRNSNotification of Transactions of Directors/PDMRs
27th May 20264:00 pmRNSResult of the 2026 Annual General Meeting
27th May 20267:00 amRNSTrading Update
12th May 20267:00 amRNSInvestor Presentation via Investor Meet Company
11th May 20267:00 amRNSNotification of Transactions of Directors/PDMRs
7th May 20267:00 amRNSIssue of Equity
30th Apr 20261:00 pmRNSFinal Dividend Payment Date
27th Apr 20267:00 amRNS2025 Annual Report and Notice of the 2026 AGM
15th Apr 20269:24 amRNSNotification of Transactions of Directors/PDMRs
31st Mar 20266:06 pmRNSHolding(s) in Company
25th Mar 20269:35 amRNSNotification Of Transactions Of Directors/PDMRs
17th Mar 20267:00 amRNSPreliminary Results
17th Mar 20267:00 amRNSPreliminary Results
16th Mar 20261:24 pmRNSNotification Of Transactions Of Directors/PDMRs
16th Mar 20261:24 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Mar 20267:00 amRNSPreliminary results presentation
11th Mar 20267:00 amRNSPreliminary results presentation
13th Feb 20267:00 amRNSNotification Of Transactions Of Directors/PDMRs
27th Jan 20267:00 amRNSChange of Registered Office Address
22nd Jan 20267:00 amRNSTrading Update
15th Jan 20269:57 amRNSNotification Of Transactions Of Directors/PDMRs
15th Dec 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs
18th Nov 202512:39 pmRNSAcquisition of Overseas Konstellation Company S.A.
12th Nov 20254:12 pmRNSNotification Of Transactions Of Directors/PDMRs
4th Nov 20257:00 amRNSTrading Update
24th Oct 20257:00 amRNSNon-Executive Directorate Changes
14th Oct 20252:54 pmRNSNotification Of Transactions Of Directors/PDMRs
9th Oct 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs
30th Sep 20254:25 pmRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
22nd Sep 20252:33 pmRNSGroup CFO succession
12th Sep 20255:11 pmRNSNotification Of Transactions Of Directors/PDMR
28th Aug 20257:00 amRNS-RInnovation Initiatives and Executive Appointment
19th Aug 20252:16 pmRNSHolding(s) in Company
14th Aug 20256:19 pmRNSHolding(s) in Company
12th Aug 20252:57 pmRNSNotification Of Transactions Of Directors/PDMR
8th Aug 20257:00 amRNSHolding(s) in Company
7th Aug 202512:14 pmRNSHolding(s) in Company
5th Aug 20257:01 amRNSJoint Venture Agreement and Executive Appointment
5th Aug 20257:00 amRNSInterim Results
29th Jul 202511:01 amRNSInvestor Presentation via Investor Meet Company
14th Jul 20252:51 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Jun 20252:41 pmRNSNotification of Transactions of Directors/PDMRs
10th Jun 20254:13 pmRNSNotification Of Transactions Of Directors/PDMRs
22nd May 202512:30 pmRNSResult of the 2025 Annual General Meeting
22nd May 20257:00 amRNSTrading Update
13th May 202512:05 pmRNSNotification Of Transactions Of Directors/PDMRs
1st May 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs
30th Apr 20257:00 amRNSGroup CFO succession
24th Apr 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs
22nd Apr 20257:00 amRNS2024 Annual Report & Notice of 2025 AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.